Articles From: Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex® to Texas Instruments board declares quarterly dividend


2014/11/17
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex® Canada NewsWire TORONTO , Nov.
Sign-up for Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex® investment picks
Teva Canada Announces the Launch of (Pr)Teva-Erlotinib, a generic of (Pr)Tarceva® Canada NewsWire TORONTO , Dec.
Sign-up for Teva Canada Announces the Launch of (Pr)Teva-Erlotinib, a generic of (Pr)Tarceva® investment picks
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the commercial availability of a liquid formulation of TREANDA ® (bendamustine HCI) Injection.
Sign-up for Teva Launches Liquid Formulation of TREANDA® (bendamustine HCI) Injection in U.S. investment picks
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that four company-sponsored abstracts evaluating the safety and efficacy of albuterol multi-dose dry-powder inhaler (MDPI), an investigational breath-actuated, dry-powder, short-acting beta-agonist (SABA), will be presented at the 2014 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Atlanta, Georgia on November 6-10, 2014.
Sign-up for Teva Presents Data for Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) at 2014 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology investment picks
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced positive findings from a Phase III clinical study that examined the safety and efficacy of QNASL ® (beclomethasone dipropionate) Nasal Aerosol 80 μg/day in children 4-11 years of age with perennial – or “year round” – allergic rhinitis (PAR). QNASL is a waterless aerosol intranasal corticosteroid spray currently available for the treatment of PAR and seasonal allergic rhinitis (SAR) in patients 12 years of age and older.
Sign-up for Teva Presents Positive Safety and Efficacy Data for QNASL® (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children with Perennial Allergic Rhinitis investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Provides 2015 Business Outlook investment picks
2014/12/11
By Angela Chen Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Provides Low-Key Revenue Outlook, Citing Competition in Generics investment picks
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that it has received a positive outcome in the decentralized procedure for its new, three-times-a-week COPAXONE ® (glatiramer acetate) 40 mg/ml formulation for the treatment of adults with relapsing forms of multiple sclerosis (RMS). The outcome follows a Positive Assessment Report from the United Kingdom, the Reference Member State’s Medicines and Healthcare Products Regulatory Agency (MHRA), and all Concerned Member States (CMS) in Europe who were involved in the procedure.
Sign-up for Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS) investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Reports Third Quarter 2014 Results investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014 investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Report Third Quarter 2014 Financial Results on October 30, 2014 investment picks
http://media.marketwire.com/attachments/201305/153616_60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149959&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 29,400 Private Sector Jobs in September, According to ADP Regional Employment Report(SM) investment picks
http://media.marketwire.com/attachments/201305/153616_60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163976&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 29,700 Private Sector Jobs in November, According to ADP Regional Employment Report(R) investment picks
http://media.marketwire.com/attachments/201305/153616_60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158094&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 30,450 Private Sector Jobs in October, According to ADP Regional Employment Report(R) investment picks
By Matthias Rieker An arbitration panel ordered a Texas advisory firm to pay a group of 19 retired Exxon Mobil Corp.
Sign-up for Texas Advisory Firm Ordered to Pay Exxon Retirees $3.8 Million investment picks
2014/12/3
By Philip van Doorn, MarketWatch The Lone Star state, home to the energy industry, suffers collateral damage Oil companies aren't the only ones taking a pounding from the tumble in crude prices.
Sign-up for Texas bank stocks dinged by drop in oil prices investment picks
2014/12/3
For comparison, the FDIC said in its quarterly banking profile that the aggregate third-quarter return on assets for all U.S. banks was 1.02% and the return on average equity was 9.04%. The aggregate ratio of noncurrent loans to total loans was 2.11%. To test reserve adequacy, it is best to compare loan charge-off rates to reserve coverage.
Sign-up for Texas bank stocks dinged by drop in oil prices -2- investment picks
DALLAS, Nov.
Sign-up for Texas Capital Bancshares, Inc. Announces Common Stock Offering investment picks
DALLAS, Oct.
Sign-up for Texas Capital Bancshares, Inc. Announces Q3 2014 Earnings Call investment picks
DALLAS, Nov.
Sign-up for Texas Capital Bancshares, Inc. Prices Common Stock Offering investment picks
2014/12/1
DALLAS, Dec.
Sign-up for Texas Capital Bank Ranks 11th in Dallas Morning News Top 100 Places to Work investment picks
Tyler Technologies, Inc. (NYSE: TYL) has signed an agreement with the Texas Comptroller of Public Accounts (CPA) for Tyler’s Orion appraisal and tax software solution.
Sign-up for Texas Comptroller of Public Accounts Signs Agreement with Tyler Technologies investment picks
Even though oil prices have softened, Texas continues to drive a historic U.S. oil boom that shows no signs of slowing down and a flood of new West Texas drilling permits drives Taylor Consulting Inc. (OTCBB:TAYO) to find and acquire the most promising properties in the Permian Basin area.
Sign-up for Texas Drives U.S. Oil Boom and TAYO’s Growing West Texas Real Estate Portfolio, Despite Softened Oil Prices investment picks
2014/11/18
- Researcher says Texas' diversification implies less severe risk scenario than 1980s - Bank economist suggests a moderate-to-mild impact in state's major markets, including Houston HOUSTON , Nov.
Sign-up for Texas economy equipped to deal if oil prices collapse, BBVA Compass economist says investment picks
NCTM uses TI-Nspire™ technology to develop Common Core-aligned classroom activities DALLAS , Oct.
Sign-up for Texas Instruments and NCTM Launch New Resources to Help Teachers Implement Common Core State Standards investment picks
DALLAS , Oct.
Sign-up for Texas Instruments board declares quarterly dividend investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex® to Texas Instruments board declares quarterly dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent